Mitesh

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Aztreonam 1g powder for solution for injection vials Aztreonam 1g powder for solution for injection vials MSN/2025/025 Tier 2 – medium impact Date of issue: 11/06/2026 Summary Aztreonam 2g powder for solution for injection vials are currently [...]

The post Medicine Supply Notification: Aztreonam 1g and 2g powder for solution for injection vials appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) Drug alert number: EL(26)A/25 Date issued: 28 May 2026 Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site. DMRC reference number: DMRC-39617807 Company name: Crescent Pharma [...]

The post MHRA Class 2 Medicines Recall: Ramipril 2.5mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.

9 new products have been added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 June 2026. Community Pharmacy England, on behalf of pharmacy owners, applied to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA) for these products to be added to the DND [...]

The post 9 products added to the Discount Not Deducted (DND) list from June 2026 appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (20/05/2026) confirmed the following list of price concessions for May 2026: Drug Pack size Price concession Alfuzosin 2.5mg tablets 60 £7.64 Aspirin 75mg tablets 28 £1.63 Benzydamine 0.15% mouthwash sugar free 300 £3.15 Bisoprolol 1.25mg tablets 28 £4.79 Carvedilol 3.125mg tablets 28 £1.91 Chloramphenicol 1% eye [...]

The post May 2026 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The MHRA has reviewed the evidence for finasteride and dutasteride and the risk of suicidal thoughts and behaviours and has recommended further measures to minimise this risk. The product [...]

The post MHRA Drug Safety Update: Finasteride and Dutasteride – updated safety warnings appeared first on Community Pharmacy England.